Jun
01
2023
EMERYVILLE, Calif., June 1, 2023 — Kyverna Therapeutics (“Kyverna”), a cell therapy company with the mission of engineering a new class of therapies for serious autoimmune diseases, today announced the U.S. Food and Drug...
Read More
From Drugs.com - Clinical Trials •
Lupus for Researchers •